Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "Peruzzo 2016 Cell Cycle"

From Bioblast
(Created page with "{{Publication |title=Peruzzo P, Comelli M, Di Giorgio E, Franforte E, Mavelli I, Brancolini C (2016) Transformation by different oncogenes relies on specific metabolic adaptation...")
Β 
Β 
(5 intermediate revisions by 4 users not shown)
Line 1: Line 1:
{{Publication
{{Publication
|title=Peruzzo P, Comelli M, Di Giorgio E, Franforte E, Mavelli I, Brancolini C (2016) Transformation by different oncogenes relies on specific metabolic adaptations. Cell Cycle [Epub ahead of print]. Β 
|title=Peruzzo P, Comelli M, Di Giorgio E, Franforte E, Mavelli I, Brancolini C (2016) Transformation by different oncogenes relies on specific metabolic adaptations. Cell Cycle 15:2656-68.
|info=[https://www.ncbi.nlm.nih.gov/pubmed/27485932 PMID: 27485932]
|info=[http://www.ncbi.nlm.nih.gov/pubmed/27485932 PMID: 27485932]
|authors=Peruzzo P, Comelli M, Di Giorgio E, Franforte E, Mavelli I, Brancolini C
|authors=Peruzzo P, Comelli M, Di Giorgio E, Franforte E, Mavelli I, Brancolini C
|year=2016
|year=2016
|journal=Cell Cycle
|journal=Cell Cycle
|abstract=Metabolic adaptations are emerging as common traits of cancer cells and tumor progression. ''In vitro'' transformation of NIH 3T3 cells allows the analysis of the metabolic changes triggered by a single oncogene. In this work, we have compared the metabolic changes induced by H-RAS and by the nuclear resident mutant of histone deacetylase 4 (HDAC4). RAS-transformed cells exhibit a dominant aerobic glycolytic phenotype characterized by up-regulation of glycolytic enzymes, reduced oxygen consumption and a defect in complex I activity. In this model of transformation, glycolysis is strictly required for sustaining the ATP levels and the robust cellular proliferation. By contrast, in HDAC4/TM transformed cells, glycolysis is only modestly up-regulated, lactate secretion is not augmented and, instead, mitochondrial oxygen consumption is increased. Our results demonstrate that cellular transformation can be accomplished through different metabolic adaptations and HDAC4/TM cells can represent a useful model to investigate oncogene-driven metabolic changes besides the Warburg effect.
|abstract=Metabolic adaptations are emerging as common traits of cancer cells and tumor progression. ''In vitro'' transformation of NIH 3T3 cells allows the analysis of the metabolic changes triggered by a single oncogene. In this work, we have compared the metabolic changes induced by H-RAS and by the nuclear resident mutant of histone deacetylase 4 (HDAC4). RAS-transformed cells exhibit a dominant aerobic glycolytic phenotype characterized by up-regulation of glycolytic enzymes, reduced oxygen consumption and a defect in complex I activity. In this model of transformation, glycolysis is strictly required for sustaining the ATP levels and the robust cellular proliferation. By contrast, in HDAC4/TM transformed cells, glycolysis is only modestly up-regulated, lactate secretion is not augmented and, instead, mitochondrial oxygen consumption is increased. Our results demonstrate that cellular transformation can be accomplished through different metabolic adaptations and HDAC4/TM cells can represent a useful model to investigate oncogene-driven metabolic changes besides the Warburg effect.
|keywords=CLN3, CPT1A, ENO2, GLA, Glycolysis, HDAC4, HDAC5, HDAC7, HDAC9, HK2, MEF2A, MEF2B, MEF2C, MEF2D, NSDHL, OXPHOS, PGK1, PKM2, RHOB, Warburg, class IIa, Mitochondria
|keywords=CLN3, CPT1A, ENO2, GLA, Glycolysis, HDAC4, HDAC5, HDAC7, HDAC9, HK2, MEF2A, MEF2B, MEF2C, MEF2D, NSDHL, OXPHOS, PGK1, PKM2, RHOB, Warburg, class IIa, Mitochondria, NIH 3T3 cells
|mipnetlab=IT Udine Grassi B
|mipnetlab=IT Udine Grassi B, IT Udine Mavelli I
}}
}}
{{Labeling
{{Labeling
|area=Respiration, nDNA;cell genetics
|area=Respiration, nDNA;cell genetics, Genetic knockout;overexpression
|diseases=Cancer
|organism=Mouse
|organism=Mouse
|tissues=Fibroblast
|preparations=Intact cells
|preparations=Intact cells
|diseases=Cancer
|couplingstates=LEAK, ROUTINE, ET
|couplingstates=LEAK, ROUTINE, ETS
|pathways=ROX
|substratestates=ROX
|instruments=Oxygraph-2k
|instruments=Oxygraph-2k
|additional=Labels, 2016-09
|additional=2016-09
}}
}}

Latest revision as of 13:59, 27 March 2018

Publications in the MiPMap
Peruzzo P, Comelli M, Di Giorgio E, Franforte E, Mavelli I, Brancolini C (2016) Transformation by different oncogenes relies on specific metabolic adaptations. Cell Cycle 15:2656-68.

Β» PMID: 27485932

Peruzzo P, Comelli M, Di Giorgio E, Franforte E, Mavelli I, Brancolini C (2016) Cell Cycle

Abstract: Metabolic adaptations are emerging as common traits of cancer cells and tumor progression. In vitro transformation of NIH 3T3 cells allows the analysis of the metabolic changes triggered by a single oncogene. In this work, we have compared the metabolic changes induced by H-RAS and by the nuclear resident mutant of histone deacetylase 4 (HDAC4). RAS-transformed cells exhibit a dominant aerobic glycolytic phenotype characterized by up-regulation of glycolytic enzymes, reduced oxygen consumption and a defect in complex I activity. In this model of transformation, glycolysis is strictly required for sustaining the ATP levels and the robust cellular proliferation. By contrast, in HDAC4/TM transformed cells, glycolysis is only modestly up-regulated, lactate secretion is not augmented and, instead, mitochondrial oxygen consumption is increased. Our results demonstrate that cellular transformation can be accomplished through different metabolic adaptations and HDAC4/TM cells can represent a useful model to investigate oncogene-driven metabolic changes besides the Warburg effect. β€’ Keywords: CLN3, CPT1A, ENO2, GLA, Glycolysis, HDAC4, HDAC5, HDAC7, HDAC9, HK2, MEF2A, MEF2B, MEF2C, MEF2D, NSDHL, OXPHOS, PGK1, PKM2, RHOB, Warburg, class IIa, Mitochondria, NIH 3T3 cells

β€’ O2k-Network Lab: IT Udine Grassi B, IT Udine Mavelli I


Labels: MiParea: Respiration, nDNA;cell genetics, Genetic knockout;overexpression  Pathology: Cancer 

Organism: Mouse  Tissue;cell: Fibroblast  Preparation: Intact cells 


Coupling state: LEAK, ROUTINE, ET  Pathway: ROX  HRR: Oxygraph-2k 

2016-09